about
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panelThe neurology of itchEvaluation of the autonomic nervous system using the FAN device -- range of normal and examples of abnormal.Skin-impedance in Fabry Disease: a prospective, controlled, non-randomized clinical studyGastrointestinal involvement in Fabry disease. So important, yet often neglected.Fabry disease and the skin: data from FOS, the Fabry outcome survey.Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey.The acetylcholine-induced flare response in evaluation of small fiber dysfunction.Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function testsA Fabry's disease heterozygote with a new mutation: biochemical, ultrastructural, and clinical investigations.Diagnosis of rare dementia syndromes: an algorithmic approach.Fabry disease: a survey of visual and ocular symptoms.Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation.[Axon-reflex based nerve fiber function assessment in the detection of autonomic neuropathy].Invited review: autonomic dysfunction in peripheral nerve disease.Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing.Autonomic involvement in inherited neuropathies.Gastrointestinal symptoms in Fabry disease: everything is possible, including treatment.Cerebrovascular complications of Fabry's disease.Fabry disease-often seen, rarely diagnosed.Enzyme therapy in Fabry disease: severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies.Enzyme replacement therapy for Fabry disease: a systematic review of available evidence.Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy.Fabry's disease: an example of cardiorenal syndrome type 5.Development of a model system for neuronal dysfunction in Fabry disease.Fabry Disease: Recognition, Diagnosis, and Treatment of Neurological Features.Improvement of sympathetic skin responses under enzyme replacement therapy in Fabry disease.Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry.Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting.Fabry disease: immunocytochemical characterization of neuronal involvement.A 4-year study of the efficacy and tolerability of enzyme replacement therapy with agalsidase alfa in 36 women with Fabry disease.Fabry disease
P2860
Q21261394-6CDF32F9-49C4-496D-9057-2E9C2EF46F7BQ27026720-802408F7-3A80-4480-9A05-6251A5CBC97CQ30492707-6A46D598-7A0F-4CC9-B61C-929AE0132351Q30850675-FC88928B-B958-415D-BA6A-1481E7AC11F3Q30991194-BD99C04F-BAA4-443C-9945-991A844A3B94Q31116015-EF06F04C-9014-4DB3-BB00-76675D067785Q33255700-591EE6BA-E25F-4029-B53E-957802552C76Q33376993-E6896728-0855-4074-B705-829B182F6D09Q33596689-6A06CE0A-41F9-41A1-ACBB-3B0D96D24521Q33597684-843F2F92-A9D6-40F0-8E4E-1B99F48EA167Q34069102-44D2548D-9897-402D-B2F5-950691A1E261Q34093662-430B9437-BEF2-4BC7-A87B-55AA7FEA1D36Q34685789-40308C5D-1773-4DE5-A20D-576D44FD4728Q35210255-6800C2C6-D694-4BD2-8C8B-9C1A327C1C0AQ35224950-F2C65C03-AEDC-45E2-A9D2-2E788A0DB414Q35994824-4EB741AB-299E-428F-9BF8-BA184794FF46Q36354775-48FECCCB-3302-48BD-9202-B7062437475DQ36772991-00F4C29B-FA15-4C97-9C3C-B2221CD7CEC7Q36805657-0B00042B-1FE8-4508-891E-78ECAAAA4A0CQ37246955-CAE54906-1389-4257-A680-82B645760035Q37471114-52746871-58FE-401C-B871-6070290DD686Q37620334-85A67740-912A-4A21-8C33-A4B1889D8D47Q37994740-DFE7109D-F08C-46F6-A309-46CD4BD7B971Q38558725-AFA701F4-A2D9-4E3B-9009-B404162A79A4Q38754923-FE957496-E8A8-474D-9C4F-93A702D9DCCEQ38844401-2B04830D-F081-4752-9A8C-80CCCD57A130Q42598253-E9F5E577-6E63-4B46-A88F-DFC47ECD7906Q44844414-6D4FC067-1294-4C91-B2A1-AFCC361A7474Q46735411-8B61A1AD-BE97-4C0A-9C21-1545720681BBQ50794570-A529E48A-3343-49D1-8A4B-67B2E84F2DCEQ51646061-0BE2B1E6-5FC4-4E61-9E18-C072897F5DC6Q56905945-AAE7604E-41CC-488B-9E72-D449F069799C
P2860
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh-hant
name
Fabry disease: impaired autonomic function.
@en
Fabry disease: impaired autonomic function.
@nl
type
label
Fabry disease: impaired autonomic function.
@en
Fabry disease: impaired autonomic function.
@nl
prefLabel
Fabry disease: impaired autonomic function.
@en
Fabry disease: impaired autonomic function.
@nl
P2093
P356
P1433
P1476
Fabry disease: impaired autonomic function.
@en
P2093
P304
P356
10.1212/WNL.32.5.498
P407
P577
1982-05-01T00:00:00Z